Genentech

Genentech is a pioneer of the biotechnology industry operating as a wholly owned member of the Roche Group, dedicated to using genetic science to discover breakthrough medicines. The enterprise engineered the first recombinant DNA pharmaceuticals and developed revolutionary targeted oncology biologics, including Herceptin, Avastin, and Rituxan, alongside leading therapies for ophthalmology and immunology. Through foundational molecular biology research and clinical translation, Genentech develops therapies for complex human diseases.